Word

Status

Dead

Status Code

404

Status Date

Monday, June 1, 2020

Serial Number

79087473

Registration Number

4148282

Registration Date

Tuesday, May 29, 2012

Mark Type

2000

Filing Date

Tuesday, June 1, 2010

Published for Opposition

Tuesday, March 13, 2012

Cancellation Date

Monday, June 1, 2020

Trademark Owner History

BEIJING YUSHENGTANG INVESTMENT GROUP CO.,LTD - Original Registrant

Classifications

5 Medicines for human purposes, namely, pharmaceutical preparations for treating respiratory illnesses, hematological illnesses, nervous system illnesses, thyroid illnesses, high white blood cells, anemia, hepatobiliary system illnesses, urinary system illnesses, infections, haemorrhoids, excessive gas, gout, digestive system illnesses, ophthalmology and otorhinolaryngology illnesses, menopause, gynecological illnesses, hair loss, immune system diseases, allergies, urinary tract illnesses, diabetes, cardiovascular illnesses, venereal diseases, liver diseases, and non-organ-specific rheumatological illnesses; pharmaceutical preparations for use in cytotoxic chemotherapy; dietetic foods adapted for medical use; tablets in round or oval shape, namely, pharmaceutical preparations for treating respiratory illnesses, hematological illnesses, nervous system illnesses, thyroid illnesses, high white blood cells, anemia, hepatobiliary system illnesses, urinary system illnesses, infections, haemorrhoids, excessive gas, gout, digestive system illnesses, ophthalmology and otorhinolaryngology illnesses, menopause, gynecological illnesses, hair loss, immune system diseases, allergies, urinary tract illnesses, diabetes, cardiovascular illnesses, venereal diseases, liver diseases, and non-organ-specific rheumatological illnesses; tablets in round or oval shape, namely, pharmaceutical preparations for use in cytotoxic chemotherapy; capsules for medicines, namely, pharmaceutical preparations for treating respiratory illnesses, hematological illnesses, nervous system illnesses, thyroid illnesses, high white blood cells, anemia, hepatobiliary system illnesses, urinary system illnesses, infections, haemorrhoids, excessive gas, gout, digestive system illnesses, ophthalmology and otorhinolaryngology illnesses, menopause, gynecological illnesses, hair loss, immune system diseases, allergies, urinary tract illnesses, diabetes, cardiovascular illnesses, venereal diseases, liver diseases, and non-organ-specific rheumatological illnesses; capsules for medicines, namely, pharmaceutical preparations for use in cytotoxic chemotherapy; pesticides; sanitary napkins; medicinal tea; pharmaceutical preparations for the treatment of teething; drugs for medical purposes, namely, pharmaceutical preparations for treating respiratory illnesses, hematological illnesses, nervous system illnesses, thyroid illnesses, high white blood cells, anemia, hepatobiliary system illnesses, urinary system illnesses, infections, haemorrhoids, excessive gas, gout, digestive system illnesses, ophthalmology and otorhinolaryngology illnesses, menopause, gynecological illnesses, hair loss, immune system diseases, allergies, urinary tract illnesses, diabetes, cardiovascular illnesses, venereal diseases, liver diseases, and non-organ-specific rheumatological illnesses; adhesive plaster for medical purposes; drug pillows, namely, sinus pillows containing aromatic substances for relief from headaches, insomnia and sinus discomfort and for reducing high blood pressure; Chinese medicine bags, namely, kits comprised of pharmaceutical preparations used for relief from headaches, insomnia and sinus discomfort; pharmaceutical preparations for treating hyperlipidemia, poor eyesight, cervical spondylosis, scapulohumeral periarthriti, chronic laryngotracheitis, and asthma; bateriostats for medical use; liquid antipruritic; pharmaceutical preparations for promoting blood circulation and to alleviate foot dropsy; Chinese medicine nostrum, namely, pharmaceuticals for treating respiratory illnesses, hematological illnesses, nervous system illnesses, thyroid illnesses, high white blood cells, anemia, hepatobiliary system illnesses, urinary system illnesses, infections, haemorrhoids, excessive gas, gout, digestive system illnesses, ophthalmology and otorhinolaryngology illnesses, menopause, gynecological illnesses, hair loss, immune system diseases, allergies, urinary tract illnesses, diabetes, cardiovascular illnesses, venereal diseases, liver diseases, and non-organ-specific rheumatological illnesses; antibiotic ointment; liquid pharmaceutical preparations used for dispelling mosquitoes, and curing eczema; and sterilising preparations

30 Tea; tea substitute; bee glue for human consumption; tea-based beverages; royal jelly for human consumption not for medicinal purposes; non-medicinal nutrition capsule in food preparation, namely, coffee capsules containing coffee for brewing; coffee; sweetmeats; bread; noodles; farinaceous food pastes for human consumption; ice cream; soya sauce; mutton seasoning; essences for foodstuffs except etheric essences and essential oils

44 Medical clinics; medical massage; hospitals; health care; medical assistance; physiotherapy; dentistry; medical nursing; pharmacy advice, namely, pharmaceutical advice; dispensing of pharmaceuticals provided by pharmacists; food nutrition consulting; providing public bath facilities for hygiene purposes; rest homes; beauty salons

Color is not claimed as a feature of the mark.
The mark consists of three Chinese characters
The transliteration of the non-Latin characters in the mark is: YUSHENGTANG.
The English translation of the foreign word(s) in the mark is imperial, rawness and hall.

Trademark Events

Jun 19, 2021

Notification Of Effect Of Cancellation Of Intl Reg E-Mailed

Jun 19, 2021

Death Of International Registration

Oct 18, 2019

Total Invalidation Processed By The Ib

Sep 16, 2019

Generic Madrid Transaction Sent To Ib

Sep 16, 2019

Generic Madrid Transaction Created

Sep 4, 2019

Total Invalidation Of Reg Ext Protection Created

Jan 4, 2019

Cancelled Section 71

May 29, 2017

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

Oct 30, 2012

Final Decision Transaction Processed By Ib

Oct 10, 2012

Final Disposition Notice Sent To Ib

Oct 10, 2012

Final Disposition Processed

Aug 29, 2012

Final Disposition Notice Created, To Be Sent To Ib

May 29, 2012

Registered-Principal Register

Apr 13, 2012

Notification Processed By Ib

Mar 21, 2012

Notification Of Possible Opposition Sent To Ib

Mar 21, 2012

Notification Of Possible Opposition Created, To Be Sent To Ib

Mar 13, 2012

Official Gazette Publication Confirmation E-Mailed

Mar 13, 2012

Published For Opposition

Feb 22, 2012

Notification Of Possible Opposition Sent To Ib

Feb 22, 2012

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Feb 22, 2012

Notification Of Notice Of Publication E-Mailed

Feb 6, 2012

Law Office Publication Review Completed

Feb 3, 2012

Exparte Appeal Terminated

Feb 3, 2012

Approved For Pub - Principal Register

Feb 3, 2012

Examiner's Amendment Entered

Feb 3, 2012

Notification Of Examiners Amendment E-Mailed

Feb 3, 2012

Examiners Amendment E-Mailed

Feb 3, 2012

Examiners Amendment -Written

Feb 2, 2012

Previous Allowance Count Withdrawn

Dec 27, 2011

Withdrawn From Pub - Og Review Query

Dec 12, 2011

Law Office Publication Review Completed

Dec 12, 2011

Approved For Pub - Principal Register

Dec 12, 2011

Examiner's Amendment Entered

Dec 12, 2011

Notification Of Examiners Amendment E-Mailed

Dec 12, 2011

Examiners Amendment E-Mailed

Dec 12, 2011

Examiners Amendment -Written

Dec 8, 2011

Teas/Email Correspondence Entered

Dec 8, 2011

Correspondence Received In Law Office

Dec 8, 2011

Assigned To Lie

Nov 21, 2011

Teas Request For Reconsideration Received

Nov 21, 2011

Ex Parte Appeal-Instituted

Nov 21, 2011

Jurisdiction Restored To Examining Attorney

Nov 21, 2011

Exparte Appeal Received At Ttab

May 20, 2011

Notification Of Final Refusal Emailed

May 20, 2011

Final Refusal E-Mailed

May 20, 2011

Final Refusal Written

Apr 29, 2011

Teas/Email Correspondence Entered

Apr 29, 2011

Correspondence Received In Law Office

Apr 29, 2011

Teas Response To Office Action Received

Nov 21, 2010

Refusal Processed By Ib

Oct 29, 2010

Non-Final Action Mailed - Refusal Sent To Ib

Oct 29, 2010

Refusal Processed By Mpu

Oct 28, 2010

Non-Final Action (Ib Refusal) Prepared For Review

Oct 27, 2010

Non-Final Action Written

Oct 26, 2010

Application Filing Receipt Mailed

Oct 22, 2010

Assigned To Examiner

Oct 22, 2010

New Application Office Supplied Data Entered In Tram

Oct 21, 2010

Sn Assigned For Sect 66a Appl From Ib